Jennifer A. Westwood

Author

Also Known As

J A Westwood, J Smith, J Westwood, J. A. Westwood, J. Westwood, Jennifer A Westwood, Jennifer A. Westwood, Jennifer Westwood, S Suresh, Westwood, Jennifer A

126

Publications

Citations

H-Index

Concepts

All Affiliations

Peter MacCallum Cancer Centre The University of Melbourne Monash University National Institutes of Health National Cancer Institute

About

Jennifer A. Westwood is an author at Peter MacCallum Cancer Centre specializing in medicine, immunotherapy, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	988
2	Cell Biology	10	10	721
3	Engineering	1	1	57
4	Health Sciences	1	1	24
5	Allergy	1	1	12

Jennifer A. Westwood

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer Michael H. Kershaw, Jennifer A. Westwood, Linda L. Parker, Clinical Cancer Research	2006	1.2K
Persistence and Efficacy of Second Generation CAR T Cell Against the LeY Antigen in Acute Myeloid Leukemia David Ritchie, Paul J. Neeson, Amit Khot, Molecular Therapy	2013	428
Redirecting Migration of T Cells to Chemokine Secreted from Tumors by Genetic Modification with CXCR2 Michael H. Kershaw, Gang Wang, Jennifer A. Westwood, Human Gene Therapy Chemokine SecretedGenetic ModificationT-regulatory CellImmunologySpecific T Cells	2002	289
Cutting Edge: Tumor Rejection Mediated by NKG2D Receptor-Ligand Interaction Is Dependent upon Perforin Yoshihiro Hayakawa, Janice M. Kelly, Jennifer A. Westwood, The Journal of Immunology	2002	181
Cutting Edge: TRAIL Deficiency Accelerates Hematological Malignancies Nadeen Zerafa, Jennifer A. Westwood, Erika Cretney, The Journal of Immunology	2005	151
Adoptive transfer of T cells modified with a humanized chimeric receptor gene inhibits growth of Lewis-Y-expressing tumors in mice Jennifer A. Westwood, Mark J. Smyth, Michele W.L. Teng, Proceedings of the National Academy of Sciences	2005	150
Multiplex immunohistochemistry accurately defines the immune context of metastatic melanoma Heloise M. Halse, Andrew J. Colebatch, Pasquale Petrone, Scientific Reports	2018	124
Tissues in Different Anatomical Sites Can Sculpt and Vary the Tumor Microenvironment to Affect Responses to Therapy Christel Devaud, Jennifer A. Westwood, Liza B. John, Molecular Therapy	2013	118
Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting Clare Y. Slaney, Bianca von Scheidt, Alexander J. Davenport, Clinical Cancer Research	2016	115
Dual-specific T cells combine proliferation and antitumor activity Michael H. Kershaw, Jennifer A. Westwood, Patrick Hwu Nature Biotechnology Cancer ImmunosurveillanceAntitumor ActivityT-regulatory CellImmunotherapyMedicine	2002	113

Page 1